Eculizumab dosing during the pregnancy | Download Scientific Diagram
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Eculizumab (Soliris) - MOA, Uses, Side effect
Eculizumab dosing in aHUS patients undergoing kidney transplantation - Renal Fellow Network
Role of Soluble C5b-9 (sC5b-9) in Dosing Adjustments of Anti-complement Therapy during Pregnancy in a Patient with History of Atypical Hemolytic Uremic Syndrome (aHUS) - ISTH Congress Abstracts
Dosing & Infusion Instruction | Soliris® (eculizumab) HCP
Recommended dosage and schedule of eculizumab in patients with aHUS | Download Table
Eculizumab dosing optimization in HSCT patients with TMA. (A) Suggested... | Download Scientific Diagram
Eculizumab Injection
Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry - ScienceDirect
ULTOMIRIS® (ravulizumab-cwvz) | Official Website
Soliris, INN-eculizumab
SOLIRIS® (eculizumab) HCP | Dosing
Eculizumab (Soliris) Criteria for Use March 2019 Exclusion Criteria Inclusion Criteria for Eculizumab in Paroxysmal Nocturnal He
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. - Abstract - Europe PMC
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria | Nature Biotechnology
CDEC FINAL RECOMMENDATION
Frontiers | Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
Recommended dosage and schedule of eculizumab in patients with aHUS | Download Table
Eculizumab dosing optimization in HSCT patients with TMA. (A) Suggested... | Download Scientific Diagram
Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT - ScienceDirect
Soliris® (eculizumab) Initiation Guide
Children | Free Full-Text | A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome
Dosing & Infusion Instruction | Soliris® (eculizumab) HCP
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use | SpringerLink
Frontiers | Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease | Haematologica
